推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33361733，021-33632861

chinasupport@letpub.com

登录 注册 新注册优惠

Surgical outcomes for older patients with glioblastoma multiforme: preoperative factors associated with decreased survival

KL Chaichana, KK Chaichana, A Olivi… - Journal of …, 2011 - thejns.org
... Glioblastoma multiforme is the most common and most malignant primary brain tumor in adults.
11 There are more than 3 newly diagnosed cases per 100,000 people every year in the US, and
the peak incidence occurs in individuals 65 years of age and older. ...
Related articles - All 4 versions

Modulation of migratory activity and invasiveness of human glioma spheroids following 5-aminolevulinic acid-based photodynamic treatment

N Etminan, C Peters, J Ficnar, S Anlasik… - Journal of …, 2011 - thejns.org
... Glioblastoma multiforme is the most frequent and aggressive malignant primary brain
tumor. The yearly incidence is 3–4 per 100,000 adults. 10 It is responsible for 2% of
cancer-related deaths, and the yearly death rate is 4–5 per 100,000. ...
Cited by 1 - Related articles - All 2 versions

Factors involved in maintaining prolonged functional independence following supratentorial glioblastoma resection

KL Chaichana, AN Halthore, SL Parker… - Journal of …, 2011 - thejns.org
... Glioblastoma (WHO Grade IV) is the most common malignant type of primary CNS tumor in
adults. 17 These tumors are characterized by their propensity to invade and infiltrate
surrounding normal brain parenchyma, making curative resection unlikely. ...
Cited by 3 - Related articles - All 3 versions

Impact of bevacizumab chemotherapy on craniotomy wound healing

AJ Clark, NA Butowski, SM Chang… - Journal of …, 2011 - thejns.org
... Glioblastoma is a highly vascular tumor and is characterized by elevated expression
of proangiogenic factors, most notably VEGF. 14,29 Increasing VEGF levels correlate
with increasing astrocytic tumor grade and with poor prognosis. ...
Cited by 2 - Related articles - All 3 versions

Safety and maximum tolerated dose of superselective intraarterial cerebral infusion of bevacizumab after osmotic blood-brain barrier disruption for recurrent malignant …

JA Boockvar, AJ Tsiouris, CP Hofstetter… - Journal of …, 2011 - thejns.org
... Glioblastoma multiforme is the most aggressive human brain tumor. Until recently, there
was no standard treatment for recurrent disease after combined chemotherapy and
radiation treatment. Intravenously administered bevacizumab ...
Cited by 4 - Related articles - All 3 versions

联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

© 2010-2024 中国: LetPub上海分公司    网站备案号：沪ICP备10217908号-1    沪公网安备号：31010402006960

增值电信业务经营许可证：沪B2-20211595

礼翰商务信息咨询（上海）有限公司      办公地址：上海市徐汇区漕溪北路88号圣爱大厦1803室

United States: Tel: 1-781-202-9968 Address: 400 5th Ave, Suite 530, Waltham, Massachusetts 02451